Robeco Institutional Asset Management B.V. Makes New Investment in Chemed Corporation $CHE

Robeco Institutional Asset Management B.V. bought a new position in Chemed Corporation (NYSE:CHE) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 980 shares of the company’s stock, valued at approximately $495,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of Chemed during the second quarter worth about $34,000. Versant Capital Management Inc lifted its position in Chemed by 7,500.0% in the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after purchasing an additional 75 shares during the period. Keating Financial Advisory Services Inc. acquired a new stake in Chemed in the second quarter valued at about $36,000. MassMutual Private Wealth & Trust FSB boosted its holdings in Chemed by 65.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock valued at $38,000 after purchasing an additional 32 shares in the last quarter. Finally, Global Retirement Partners LLC purchased a new stake in Chemed in the 2nd quarter valued at approximately $49,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Activity at Chemed

In related news, CEO Kevin McNamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $539.51, for a total value of $1,079,020.00. Following the completion of the transaction, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at $37,991,215.18. This trade represents a 2.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Patrick Grace sold 190 shares of Chemed stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total value of $101,080.00. Following the transaction, the director directly owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. This represents a 5.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 9,190 shares of company stock valued at $4,833,160 in the last ninety days. Corporate insiders own 3.33% of the company’s stock.

Chemed Trading Down 0.1%

Shares of CHE opened at $512.24 on Tuesday. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. The firm has a market capitalization of $6.69 billion, a P/E ratio of 25.73, a PEG ratio of 2.06 and a beta of 0.51. The firm’s 50-day moving average is $514.82 and its two-hundred day moving average is $461.28.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period last year, the firm earned $4.27 EPS. On average, research analysts predict that Chemed Corporation will post 23.55 earnings per share for the current fiscal year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Monday, August 17th were issued a $0.70 dividend. The ex-dividend date was Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is currently 14.06%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on CHE shares. UBS Group initiated coverage on Chemed in a research report on Friday, September 25th. They set a “buy” rating and a $650.00 target price on the stock. Wall Street Zen upgraded Chemed from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 10th. Oppenheimer lifted their price target on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Weiss Ratings raised Chemed from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Finally, Bank of America reiterated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Two equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $554.60.

About Chemed

Chemed Corporation (NYSE:CHE) is a Cincinnati, Ohio-based company that provides healthcare and residential and commercial services through two operating businesses: VITAS Healthcare and Roto-Rooter. Its operations serve customers primarily in the United States, with Roto-Rooter also providing services in Canada.

VITAS Healthcare is a provider of hospice and palliative care for individuals with advanced illnesses. The business delivers care in patients’ homes, hospice inpatient units, hospitals, nursing facilities and other care settings.